Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q3 2023 Earnings Call Transcript November 8, 2023 Amicus Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.07, expectations were $-0.08. Operator: Good morning, ladies and gentlemen and welcome to the Amicus Therapeutics Third Quarter 2023 Financial Results Conference Call and webcast. [Operator Instructions] As a reminder, this conference is being […]
Related Keywords
United Kingdom , Germany , Austria , United States , Jeff Castelli , Simon Harford , Bradley Campbell , Chief Development Officer , Chief Financial Officer , Highest Alcohol Consumption , Gins Under , Amicus Therapeutics , Xchange Rates , Chief Executive Officer , Forward Looking Statements , Andrew Faughnan ,
vimarsana.com © 2020. All Rights Reserved.